foto1 foto2 foto3 foto4 foto5


Contact us:  Office: +7 495 109 8808  •  WhatsApp: +7 985 908 5818  •    •  regdrug.com  •  pharegis.ru

Activities

Regulatory Knowledge Base

Preclinical studies, in vitro studies for drugs, generics and biopharmaceuticals by regulatory CRO Pharegis in Russia

In Vitro Preclinical Studies in Russia

are commonly used for several procedures like addition of new dosage (that require new registration procedure)

  1. Biowaver testing (test of comparative dissolution kinetics of drugs) for every dosage of a pharmaceutical to be registered;
  2. Comparative studies of antibiotic activity;
  3. Microbiology studies;
  4. Viral safety studies;
  5. Additional pharmacokinetic variables assessment as part of a clinical study;
  6. Patient genotyping for highly-variable metabolism pharmaceuticals in frames of bioequivalence or therapeutical equivalence studies;
  7. Pharmacogenetic studies.

Contact us today and we provide you free calculation and initial consultation on in vitro study budget and timeline. Our experts will discuss every detail of your project and you will receive working solution that will bring you Clear Regulatory Answers for Your Business.

SHARE THIS BY:

Pharma Regulatory News

Feed - News and features

PharmaTimes: News RSS

EMA News

ClinicalTrials.gov News